Expanded Access Protocol Submitted to the FDA
In January 2019, MAPS Public Benefit Corporation (MAPS PBC) sent a formal protocol to the U.S. Food and Drug Administration (FDA) for an Expanded Access program for MDMA-assisted psychotherapy for posttraumatic …
